It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JNJ’s FA Score shows that 4 FA rating(s) are green whilePG’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
JNJ’s TA Score shows that 7 TA indicator(s) are bullish while MMM’s TA Score has 3 bullish TA indicator(s), and PG’s TA Score reflects 6 bullish TA indicator(s).
JNJ (@Pharmaceuticals: Major) experienced а +4.81% price change this week, while PG (@Household/Personal Care) price change was +1.52% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.79%. For the same industry, the average monthly price growth was +4.32%, and the average quarterly price growth was +10.25%.
The average weekly price growth across all stocks in the @Household/Personal Care industry was +0.47%. For the same industry, the average monthly price growth was +2.71%, and the average quarterly price growth was +5.02%.
JNJ is expected to report earnings on Oct 21, 2025.
PG is expected to report earnings on Oct 15, 2025.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Household/Personal Care (+0.47% weekly)Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
JNJ | MMM | PG | |
Capitalization | 380B | 58.7B | 382B |
EBITDA | 23.3B | -6.76B | 22.6B |
Gain YTD | 15.541 | 19.551 | -5.744 |
P/E Ratio | 30.34 | 10.77 | 26.90 |
Revenue | 85.2B | 32.7B | 83.9B |
Total Cash | 22.9B | 5.99B | 7.89B |
Total Debt | 29.3B | 16.9B | 33.7B |
JNJ | MMM | PG | ||
---|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 9 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | 92 Overvalued | 44 Fair valued | |
PROFIT vs RISK RATING 1..100 | 29 | 56 | 27 | |
SMR RATING 1..100 | 33 | 14 | 32 | |
PRICE GROWTH RATING 1..100 | 31 | 25 | 61 | |
P/E GROWTH RATING 1..100 | 81 | 97 | 64 | |
SEASONALITY SCORE 1..100 | 50 | 85 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
JNJ's Valuation (20) in the Pharmaceuticals Major industry is in the same range as PG (44) in the Household Or Personal Care industry, and is significantly better than the same rating for MMM (92) in the Industrial Conglomerates industry. This means that JNJ's stock grew similarly to PG’s and significantly faster than MMM’s over the last 12 months.
PG's Profit vs Risk Rating (27) in the Household Or Personal Care industry is in the same range as JNJ (29) in the Pharmaceuticals Major industry, and is in the same range as MMM (56) in the Industrial Conglomerates industry. This means that PG's stock grew similarly to JNJ’s and similarly to MMM’s over the last 12 months.
MMM's SMR Rating (14) in the Industrial Conglomerates industry is in the same range as PG (32) in the Household Or Personal Care industry, and is in the same range as JNJ (33) in the Pharmaceuticals Major industry. This means that MMM's stock grew similarly to PG’s and similarly to JNJ’s over the last 12 months.
MMM's Price Growth Rating (25) in the Industrial Conglomerates industry is in the same range as JNJ (31) in the Pharmaceuticals Major industry, and is somewhat better than the same rating for PG (61) in the Household Or Personal Care industry. This means that MMM's stock grew similarly to JNJ’s and somewhat faster than PG’s over the last 12 months.
PG's P/E Growth Rating (64) in the Household Or Personal Care industry is in the same range as JNJ (81) in the Pharmaceuticals Major industry, and is somewhat better than the same rating for MMM (97) in the Industrial Conglomerates industry. This means that PG's stock grew similarly to JNJ’s and somewhat faster than MMM’s over the last 12 months.
JNJ | MMM | PG | |
---|---|---|---|
RSI ODDS (%) | 1 day ago32% | 1 day ago56% | 1 day ago62% |
Stochastic ODDS (%) | 1 day ago47% | 1 day ago64% | 1 day ago48% |
Momentum ODDS (%) | 1 day ago42% | 1 day ago52% | 1 day ago45% |
MACD ODDS (%) | 1 day ago39% | 1 day ago55% | 1 day ago49% |
TrendWeek ODDS (%) | 1 day ago40% | 1 day ago51% | 1 day ago43% |
TrendMonth ODDS (%) | 1 day ago38% | 1 day ago54% | 1 day ago36% |
Advances ODDS (%) | 1 day ago40% | 6 days ago54% | 5 days ago44% |
Declines ODDS (%) | 8 days ago43% | 1 day ago47% | 8 days ago38% |
BollingerBands ODDS (%) | 1 day ago36% | 1 day ago53% | 1 day ago52% |
Aroon ODDS (%) | 1 day ago40% | 1 day ago53% | 1 day ago36% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IPO | 46.02 | 0.77 | +1.71% |
Renaissance IPO ETF | |||
TLTD | 83.65 | 0.53 | +0.64% |
FlexShares Mstar DevMks exUS FctTilt ETF | |||
PSFJ | 31.27 | 0.07 | +0.24% |
Pacer Swan SOS Flex (July) ETF | |||
ZJAN | 26.44 | 0.02 | +0.08% |
Innovator Equity Defined Protection ETF - 1 Yr January | |||
DFSV | 30.26 | -0.10 | -0.33% |
Dimensional US Small Cap Value ETF |